https://www.puertoricohealthcaredaily.com/article/911949613-kraig-biocraft-laboratories-commissions-new-production-rearing-center-to-support-accelerating-spider-silk-scale-up Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:05:00+00:00 Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949538-invivyd-and-collaborators-author-new-manuscript-evaluating-early-tolerability-of-covid-monoclonal-antibody-and-comparing-results-to-covid-vaccination Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:01:00+00:00 Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.puertoricohealthcaredaily.com/article/911949313-4basebio-launches-enzymatic-ssdna-platform Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 4basebio Launches Enzymatic ssDNA Platform https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://www.puertoricohealthcaredaily.com/article/911949353-apogee-therapeutics-provides-pipeline-progress-and-reports-first-quarter-2026-financial-results Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png https://www.puertoricohealthcaredaily.com/article/911949410-fractyl-health-authorized-to-initiate-first-in-human-trial-of-rjva-001-in-the-netherlands-first-gene-therapy-candidate-to-enter-clinical-development Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes https://ml.globenewswire.com/media/3a379315-9c07-4655-883e-7e7f26c67778/small/fractyl-logo-png.png https://www.puertoricohealthcaredaily.com/article/911949413-sagimet-biosciences-to-present-mechanism-of-action-data-for-its-fasn-inhibitors-at-the-society-for-investigative-dermatology-in-chicago Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.puertoricohealthcaredaily.com/article/911949451-actuate-therapeutics-announces-fda-clearance-of-ind-for-oral-elraglusib-and-strategic-initiatives-to-advance-the-elraglusib-development-program Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949531-alpha-tau-announces-groundbreaking-interim-results-from-its-u-s-alpha-dart-recurrent-glioblastoma-trial-with-100-local-disease-control-67 Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949545-dark-horse-consulting-group-and-kuntuo-announce-memorandum-of-understanding-providing-cell-and-gene-therapy-developers-with-an-accelerated-path-to Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949571-rezolute-to-participate-in-upcoming-investor-conferences Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Rezolute to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/bbe03de3-6870-4230-b875-d8965a3d1b97/small/rezolute-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949580-mbx-biosciences-provides-obesity-portfolio-update-including-initial-phase-1-data-for-mbx-4291-supporting-potential-for-once-monthly-dosing Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing https://ml.globenewswire.com/media/5499b327-bce0-4a3f-96a7-04a38b68a99f/small/mbx-logos-final-full-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949598-lexeo-therapeutics-reports-first-quarter-2026-financial-results-and-operational-highlights Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights https://ml.globenewswire.com/media/85c275df-e665-426f-a3bc-4a839a0b34d3/small/lexeo-logo-png.png https://www.puertoricohealthcaredaily.com/article/911949611-gain-therapeutics-reports-financial-results-for-first-quarter-2026-and-provides-corporate-update Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png https://www.puertoricohealthcaredaily.com/article/911949616-erasca-announces-clinical-trial-collaboration-and-supply-agreement-with-merck-to-evaluate-eras-0015-in-combination-with-keytruda-pembrolizumab Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://www.puertoricohealthcaredaily.com/article/911949619-conavi-medical-corp-announces-proposed-public-offering-of-common-shares-and-pre-funded-warrants Puerto Rico Healthcare Daily en PressRelease 2026-05-11T11:00:00+00:00 Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants https://ml.globenewswire.com/media/4a28f1c0-f99d-4940-b2a7-201ab98cdaff/small/conavi-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911949660-new-data-shows-5x-growth-in-medical-crowdfunding-across-europe Puerto Rico Healthcare Daily en PressRelease 2026-05-11T10:39:06+00:00 New data shows 5x growth in medical crowdfunding across Europe https://ml.globenewswire.com/media/5064bb8d-e4da-4bb6-9c7f-7e699af0823c/medium/reimbursement-gap-in-medical-insurance-in-eu.png https://www.puertoricohealthcaredaily.com/article/911949541-certara-reports-first-quarter-2026-financial-results Puerto Rico Healthcare Daily en PressRelease 2026-05-11T10:25:00+00:00 Certara Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6da79355-1c12-4676-93c4-f765b2948060/small/rgbcertara-logo-large-blackhigh-res-png.png https://www.puertoricohealthcaredaily.com/article/911930501-alvotech-announces-completion-of-fda-surveillance-inspection-at-reykjavik-facility Puerto Rico Healthcare Daily en PressRelease 2026-05-11T08:30:00+00:00 Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911922200-ena-respiratory-successfully-completes-first-part-of-phase-ii-study-of-inna-051-nasal-spray-designed-to-protect-against-symptomatic-viral-respiratory Puerto Rico Healthcare Daily en PressRelease 2026-05-11T08:00:00+00:00 ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections https://ml-eu.globenewswire.com/media/84159208-c519-49a5-86c6-56151e3ab92b/small/ena-png.png https://www.puertoricohealthcaredaily.com/article/911922246-anaveon-announces-presentation-of-positive-anv600-clinical-data-at-asco-2026-and-actively-seeks-partners-for-its-legacy-oncology-portfolio Puerto Rico Healthcare Daily en PressRelease 2026-05-11T08:00:00+00:00 Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio https://ml.globenewswire.com/media/376f71da-1a19-4a9a-bb0a-5d12feb63780/small/logo-anaveon-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911914256-positive-results-from-pulsesight-s-phase-i-clinical-trial-of-pst-611-in-dry-amd-geographic-atrophy-presented-at-arvo-2026 Puerto Rico Healthcare Daily en PressRelease 2026-05-11T07:00:00+00:00 Positive Results from PulseSight’s Phase I Clinical Trial of PST-611 in Dry AMD/Geographic Atrophy Presented at ARVO 2026 https://ml-eu.globenewswire.com/media/9f8ee53c-2465-4c3c-870e-4077c6a39edb/small/pulsesight-therapeutics-logo-horizontal-full-gradient-mark-0.png https://www.puertoricohealthcaredaily.com/article/911914260-nxera-pharma-announces-progress-of-out-licensing-of-gpcr-targeted-program-and-participation-in-series-a-financing Puerto Rico Healthcare Daily en PressRelease 2026-05-11T06:34:51+00:00 Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.puertoricohealthcaredaily.com/article/911900174-pulsetto-vagus-nerve-stimulator-2026-claims-features-and-feedback-under-investigation Puerto Rico Healthcare Daily en PressRelease 2026-05-11T04:51:36+00:00 Pulsetto Vagus Nerve Stimulator 2026 Claims, Features, and Feedback Under Investigation https://ml.globenewswire.com/Resource/Download/a32ce3a3-1115-4d13-a47c-0516fa94b0b7/whatsapp-image-2026-05-11-at-9-56-52-am.jpeg https://www.puertoricohealthcaredaily.com/article/911844395-radnet-reports-record-first-quarter-financial-results-and-revises-upwards-2026-imaging-center-financial-guidance-ranges-for-revenue-adjusted-ebitda Puerto Rico Healthcare Daily en PressRelease 2026-05-10T20:05:00+00:00 RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow https://ml.globenewswire.com/media/0df5f357-aa64-4998-a83f-f1561aef685d/small/logo-radnet-profile2-jpg.jpg https://www.puertoricohealthcaredaily.com/article/911806251-healthy-moms-healthy-babies-america-launches-national-campaign-to-cut-u-s-maternal-mortality-in-half-within-five-years Puerto Rico Healthcare Daily en PressRelease 2026-05-10T15:00:00+00:00 Healthy Moms, Healthy Babies America Launches National Campaign to Cut U.S. Maternal Mortality in Half Within Five Years https://ml.globenewswire.com/media/ZDAzNWUwNTYtNjI5ZC00YWZlLWI0ZTctYWVkYzBiYmNlZTQ4LTUwMDE2MjMzOC0yMDI2LTA1LTEwLWVu/tiny/Healthy-Moms-Healthy-Babies-Am.png https://www.puertoricohealthcaredaily.com/article/911793196-moonlake-immunotherapeutics-announces-positive-outcome-from-its-final-pre-bla-meeting-with-the-u-s-fda-and-reports-first-quarter-2026-financial Puerto Rico Healthcare Daily en PressRelease 2026-05-10T13:00:00+00:00 MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results https://ml-eu.globenewswire.com/media/f894fe8c-bb73-4375-a7de-30c9195f573a/small/moonlake-logo-png.png https://www.puertoricohealthcaredaily.com/article/911770267-whiteswell-announces-primary-clinical-trial-results-simultaneously-at-heart-failure-2026-congress-and-in-european-journal-of-heart-failure-related-to Puerto Rico Healthcare Daily en PressRelease 2026-05-10T09:09:00+00:00 WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure https://ml.globenewswire.com/media/f735fa38-d2f5-476c-8e2b-e73cfd79e08e/small/whiteswell-logo-002-png.png https://www.puertoricohealthcaredaily.com/article/911720880-a-pint-for-kim-blood-drive-breaks-illinois-record-for-the-seventh-year-in-a-row-with-over-650-donations-in-one-day Puerto Rico Healthcare Daily en PressRelease 2026-05-10T00:57:12+00:00 A Pint for Kim Blood Drive Breaks Illinois Record for the Seventh Year in a Row with over 650 Donations in One Day https://ml.globenewswire.com/media/5cbbb955-4170-4c7b-8641-17d04c4e4327/medium/a-pint-for-kim-blood-drive-breaks-illinois-record-for-sevent.jpeg